≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Endocrine gland, other/unspecified

DOID EFO MESH SNOMED PheWeb

CD2_BENIGN_ENDOCRINE_NOS

sebaceous adenocarcinoma: An adenocarcinoma with sebaceous differentiation. It presents as a painless mass and it may be multifocal. It grows in the ocular adnexae and in the skin of head and neck, trunk, genitals, and extremities. It is characterized by the presence of malignant cells with multivesicular and clear cytoplasm. It may recur and metastasize.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D35.7&, D35.9&
Hospital discharge: ICD-9 227[8-9]
Hospital discharge: ICD-8 226[8-9]
Cause of death: ICD-10 D35.7&, D35.9&
Cause of death: ICD-9 227[8-9]
Cause of death: ICD-8 226[8-9]

2 out of 7 registries used, show all original rules.

94

diagram downward connector

Check minimum number of events None

94

diagram downward connector

Include endpoints None

94

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

93

diagram downward connector
CD2_BENIGN_ENDOCRINE_NOS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Endocrine gland, other/unspecified based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 93 65 28
Unadjusted prevalence (%) 0.02 0.03 0.02
Mean age at first event (years) 46.88 44.41 52.61

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_ENDOCRINE_NOS – Benign neoplasm: Endocrine gland, other/unspecified
GWS hits:

Survival analyses between endpoints

↥

Plot

before Benign neoplasm: Endocrine gland, other/unspecified
after Benign neoplasm: Endocrine gland, other/unspecified

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm: Endocrine gland, other/unspecified

↥

Endpoint not on priority list, no data to show.